Business
Starpharma (ASX:SPL) share price rebounds after receiving Indian approval for COVID-19 product
Image source: Getty Images
The Starpharma Holdings Limited (ASX: SPL) share price has bounced back from weakness this morning and is pushing higher late on Friday.
In afternoon trade, the biotechnology company’s shares are up 1% to $1.69.
This latest gain means the Starpharma…
Continue Reading
-
Business22 hours agoWhy Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher
-
Business24 hours agoMacquarie increases price target for Qantas shares
-
Noosa News24 hours agoHoyts Is Set to Launch Up to Five New IMAX Screens in Australia — Including at Melbourne Central Before the End of 2025
-
Noosa News22 hours agoCommonwealth Bank executive Christopher James McCann found dead in Springbrook National Park